Gilead, Celgene, Biogen Head List Of Most Productive Biopharmas
Executive Summary
Gilead, Celgene, Biogen and Baxter’s pharma business top the list of most productive pharma R&D companies, and all of those, except for Baxter, also are among the top five on the list of the industry’s overall best performers in 2013, as measured by a variety of growth metrics. For R&D productivity, the sweet spot on spend is $1 billion to $2 billion per year.